Relmada Therapeutics Inc (RLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RLMD | ZTS | TAK | UTHR | NBIX |
| Company | Relmada Therapeutics Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.3515 | 170.07 | 13.34 | 379.59 | 137.00 |
| High | 0.3985 | 170.94 | 13.37 | 383.00 | 140.00 |
| Low | 0.3515 | 166.90 | 13.11 | 356.06 | 134.26 |
| Last | 0.3533 | 167.01 | 13.11 | 357.55 | 135.45 |
| Change | -0.0084 | -3.78 | -0.25 | -22.14 | -1.24 |
| % Change | -2.32% | -2.21% | -1.87% | -5.83% | -0.91% |
| Volume | 841,001 | 2,699,070 | 1,284,968 | 537,244 | 2,122,985 |
| 20-Day Average Volume | 2,132,994 | 2,303,082 | 1,785,670 | 272,289 | 955,020 |
| Previous Close | 0.3617 | 170.79 | 13.36 | 379.69 | 136.69 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5304 | 175.94 | 13.52 | 369.05 | 128.05 |
| 20-Day Raw Stochastic | 0.17% | 0.47% | 1.08% | 1.62% | 78.64% |
| 20-Day Relative Strength | 19.35% | 35.06% | 37.75% | 44.51% | 64.56% |
| Weighted Alpha | -57.62 | -14.48 | -8.51 | +57.36 | +5.14 |
| Today's Opinion | 100% Sell | 72% Sell | 88% Sell | 56% Buy | 24% Buy |
| Previous Opinion | 100% Sell | 72% Sell | 88% Sell | 88% Buy | 24% Buy |
| Last Month's Opinion | 40% Sell | 24% Sell | 40% Sell | 64% Buy | 80% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.92% since 12/11/24 | -5.68% since 12/11/24 | -3.21% since 12/11/24 | -1.30% since 12/11/24 | +5.67% since 12/11/24 |
| Low | 0.3500 on 12/13/24 | 167.03 on 12/18/24 | 13.11 on 12/18/24 | 357.02 on 12/18/24 | 125.61 on 12/13/24 |
| High | 0.4168 on 12/12/24 | 181.85 on 12/13/24 | 13.59 on 12/12/24 | 383.00 on 12/18/24 | 140.00 on 12/18/24 |
| 1-Month | |||||
| %Chg | -88.24% since 11/18/24 | -5.28% since 11/18/24 | -2.99% since 11/18/24 | -0.49% since 11/18/24 | +15.20% since 11/18/24 |
| Low | 0.3500 on 12/13/24 | 167.03 on 12/18/24 | 13.11 on 12/18/24 | 353.65 on 11/19/24 | 115.27 on 11/19/24 |
| High | 3.3991 on 12/02/24 | 181.85 on 12/13/24 | 14.04 on 12/03/24 | 383.00 on 12/18/24 | 140.00 on 12/18/24 |
| 3-Month | |||||
| %Chg | -89.82% since 09/18/24 | -14.95% since 09/18/24 | -11.44% since 09/18/24 | +4.33% since 09/18/24 | +13.05% since 09/18/24 |
| Low | 0.3500 on 12/13/24 | 167.03 on 12/18/24 | 13.11 on 12/18/24 | 342.02 on 10/23/24 | 110.95 on 10/03/24 |
| High | 3.9800 on 10/28/24 | 200.33 on 09/19/24 | 14.94 on 09/19/24 | 417.82 on 11/08/24 | 140.00 on 12/18/24 |
| 6-Month | |||||
| %Chg | -88.28% since 06/18/24 | -1.51% since 06/18/24 | +3.59% since 06/18/24 | +16.80% since 06/18/24 | +3.54% since 06/18/24 |
| Low | 0.3500 on 12/13/24 | 166.45 on 06/26/24 | 12.57 on 06/20/24 | 302.71 on 06/20/24 | 110.95 on 10/03/24 |
| High | 4.4700 on 07/11/24 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 417.82 on 11/08/24 | 157.98 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 10,914 | 77,054,472 | 42,509,848 | 16,951,260 | 13,839,452 |
| Shares Outstanding, K | 30,174 | 451,165 | 3,181,875 | 44,645 | 101,247 |
| Annual Sales | 0 | 8,544,000,000 | 29,419,960,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -98,790,000 | 2,344,000,000 | 994,060,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 0 | 2,388,000,000 | 7,903,930,000 | 748,900,000 | 622,100,000 |
| Last Quarter Net Income | -21,730,000 | 682,000,000 | 618,620,000 | 309,100,000 | 129,800,000 |
| 60-Month Beta | 0.35 | 0.89 | 0.51 | 0.54 | 0.34 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.72 on 11/07/24 | 1.58 on 11/04/24 | 0.44 on 10/31/24 | 6.39 on 10/30/24 | 1.24 on 10/30/24 |
| Latest Earnings Date | 11/07/24 | 02/11/25 | 02/06/25 | 10/30/24 | 02/05/25 |
| Most Recent Dividend | N/A | 0.432 on 10/31/24 | 0.267 on 09/30/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 01/21/25 | 09/30/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 30.52 | 8.79 | 16.37 | 35.67 |